PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Hironobu Sasano Selected Research
Estrogens (Estrogen)
07/2008
Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
06/2008
Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
02/2008
Intracrinology of estrogens and androgens in breast carcinoma.
12/2007
Biological Roles of Estrogen and Progesterone in Human Endometrial Carcinoma - New developments in potential endocrine therapy for endometrial cancer -.
06/2007
Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor.
05/2007
Ovarian epithelial carcinoma with estrogen-producing stroma.
04/2006
A case of estrogen-secreting adrenocortical carcinoma with subclinical Cushing's syndrome.
12/2005
Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
09/2005
Estrogen inhibits cell proliferation through in situ production in human thymoma.
09/2005
Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
02/2005
Estrogen actions and in situ synthesis in human vascular smooth muscle cells and their correlation with atherosclerosis.
12/2003
Intracrine mechanism of estrogen synthesis in breast cancer.
09/2003
Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
01/2002
In situ production of estrogens in human breast carcinoma.
Articles by Research Topic
Disease
18
Carcinoma (Carcinomatosis)
07/2008 - 01/2002
11
Neoplasms (Cancer)
07/2008 - 06/2002
8
Breast Neoplasms (Breast Cancer)
08/2007 - 09/2003
6
Endometrial Neoplasms (Endometrial Cancer)
06/2008 - 06/2003
3
Adrenocortical Adenoma (Disease, Conn's)
11/2007 - 08/2003
3
Cushing Syndrome
10/2006 - 02/2004
3
Adenoma (Adenomas)
08/2003 - 11/2002
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2008 - 01/2007
2
Ovarian Neoplasms (Ovarian Cancer)
03/2007 - 12/2005
2
Hyperaldosteronism (Conn Syndrome)
11/2006 - 01/2005
2
Prostatic Neoplasms (Prostate Cancer)
06/2006 - 03/2005
2
Small Cell Carcinoma
10/2005 - 07/2005
2
Thymoma (Thymic Carcinoma)
09/2005 - 05/2003
2
Hyperplasia
02/2004 - 04/2002
1
Heart Failure
09/2008
1
Osteosarcoma (Osteogenic Sarcoma)
03/2008
1
Noninfiltrating Intraductal Carcinoma (DCIS)
03/2008
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2007
1
Aggressive Fibromatosis (Desmoid)
11/2006
1
Adrenocortical Carcinoma
04/2006
1
Atherosclerosis (Atheroma)
02/2005
1
Ulcerative Colitis
11/2004
1
Rheumatoid Arthritis
03/2004
1
Ascorbic Acid Deficiency (Vitamin C Deficiency)
11/2003
1
Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2003
1
Chronic Kidney Failure (Chronic Renal Failure)
08/2003
1
Fibrosis (Cirrhosis)
06/2003
1
Pheochromocytoma
06/2002
1
Neuroblastoma
06/2002
1
Endometriosis (Adenomyosis)
05/2002
Drug/Important Bio-Agent (IBA)
14
Estrogens (Estrogen)
FDA Link
07/2008 - 01/2002
8
Aromatase (CYP19)
IBA
07/2008 - 05/2002
6
Enzymes
IBA
03/2008 - 03/2005
5
Aldosterone
IBA
11/2007 - 08/2003
5
Steryl-Sulfatase (Steroid Sulfatase)
IBA
06/2006 - 06/2003
5
11-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)
IBA
01/2005 - 11/2002
4
estrone sulfotransferase
IBA
06/2006 - 06/2003
3
Hormones
IBA
03/2008 - 05/2003
3
Steroid Receptors (Steroid Receptor)
IBA
03/2008 - 03/2004
3
Progesterone
FDA Link
Generic
12/2007 - 11/2002
3
Hydrocortisone (Cortisol)
FDA Link
Generic
06/2007 - 08/2003
3
Progesterone Receptors (Progesterone Receptor)
IBA
12/2006 - 07/2002
3
Adrenocorticotropic Hormone (ACTH)
FDA Link
10/2006 - 04/2002
2
Adrenomedullin
IBA
09/2008 - 07/2008
2
Steroids
IBA
03/2008 - 09/2007
2
Androgens
IBA
02/2008 - 06/2007
2
Protein Isoforms (Isoforms)
IBA
12/2006 - 07/2002
2
Urocortins
IBA
01/2006 - 11/2004
1
Estrogen Receptors
IBA
07/2008
1
urotensin II
IBA
05/2008
1
Biological Markers (Surrogate Marker)
IBA
10/2007
1
capecitabine (Xeloda)
FDA Link
10/2007
1
SOM-230
IBA
07/2007
1
Somatostatin Receptors (Somatostatin Receptor)
IBA
07/2007
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
07/2007
1
cyclin B1
IBA
05/2007
1
Cyclins
IBA
03/2007
1
Advanced Glycosylation End Products
IBA
01/2007
1
PPAR gamma
IBA
07/2006
1
Ligands
IBA
07/2006
1
Cholesterol
IBA
04/2005
1
Cytochromes
IBA
04/2005
1
Transcription Factors (Transcription Factor)
IBA
04/2005
1
Oxidoreductases
IBA
04/2005
1
Sodium
IBA
01/2005
1
ERRalpha estrogen-related receptor
IBA
07/2004
1
Vasopressins (Vasopressin)
IBA
02/2004
1
Ammonia
IBA
11/2003
1
Mineralocorticoid Receptors (Mineralocorticoid Receptor)
IBA
06/2003
1
progesterone receptor B
IBA
06/2003
1
3 (or 17)-beta-hydroxysteroid dehydrogenase
IBA
06/2003
1
prolactin-releasing peptide
IBA
06/2002
1
CCAAT-Enhancer-Binding Proteins
IBA
05/2002
1
CCAAT-Enhancer-Binding Protein-beta
IBA
05/2002
Therapy/Procedure
1
Chemoprevention
07/2006
1
Drug Therapy (Chemotherapy)
10/2005
1
Colectomy
01/2005